Evidence map›Paper›PMID 25926124›Full record

ReviewEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2016

Ameloblastoma: a clinical review and trends in management.

Andrew C McClary, Robert B West, Ashley C McClary, Jonathan R Pollack, Nancy J Fischbein, Christopher F Holsinger, John Sunwoo, A Dimitrios Colevas, Davud Sirjani

Abstract readReview
PubMed Publisher
In one paragraph

Review in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 4 pooled it
16.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 4 syntheses or guidelines pooled it, 260 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Observational
  19. Observational
  20. Review

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Andrew C McClaryDepartment of Pathology, Stanford University, 300 Pasteur Drive, Lane 235, Stanford, CA, 94305-5324, USA. amcclary@stanford.edu.
Robert B WestDepartment of Pathology, Stanford University, 300 Pasteur Drive, Lane 235, Stanford, CA, 94305-5324, USA.
Ashley C McClaryDepartment of Pediatrics, Stanford University, 300 Pasteur Dr., Stanford, CA, 94305, USA.
Jonathan R PollackDepartment of Pathology, Stanford University, 300 Pasteur Drive, Lane 235, Stanford, CA, 94305-5324, USA.
Nancy J FischbeinDepartment of Radiology, Stanford University, 300 Pasteur Dr., Stanford, CA, 94305, USA.
Christopher F HolsingerDivision of Head and Neck Surgery, Department of Otolaryngology, Stanford University, 801 Welch Rd., MC 5739, Stanford, CA, 94305, USA.
John SunwooDivision of Head and Neck Surgery, Department of Otolaryngology, Stanford University, 801 Welch Rd., MC 5739, Stanford, CA, 94305, USA.
A Dimitrios ColevasDivision of Oncology, Department of Medicine, Stanford University, 300 Pasteur Dr., Stanford, CA, 94305, USA.
Davud SirjaniDivision of Head and Neck Surgery, Department of Otolaryngology, Stanford University, 801 Welch Rd., MC 5739, Stanford, CA, 94305, USA. dsirjani@ohns.stanford.edu.
Stanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ameloblastoma is a rare odontogenic neoplasm of the mandible and maxilla, with multiple histologic variants, and high recurrence rates if improperly treated. The current mainstay of treatment is wide local excision with appropriate margins and immediate reconstruction. Here we review the ameloblastoma literature, using the available evidence to highlight the change in management over the past several decades. In addition, we explore the recent molecular characterization of these tumors which may point towards new potential avenues of personalized treatment.

Indexed as

AmeloblastomaJaw NeoplasmsDisease ManagementHumansMandibleMandibular NeoplasmsMaxillaOral Surgical ProceduresPlastic Surgery ProceduresPrognosisAmeloblastomaBRAFClinical reviewGenomicsHead and neck surgeryPersonalized medicineSHH

Identifiers

PMID25926124
OpenAlexW2080005648

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.